Apolipoprotein E as a β-amyloid-independent factor in Alzheimer's disease

45Citations
Citations of this article
57Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

APOE, which encodes apolipoprotein E, is the most prevalent and best established genetic risk factor for late-onset Alzheimer's disease. Current understanding of Alzheimer's disease pathophysiology posits an important role for apolipoprotein E in the disease cascade via its interplay with β-amyloid. However, evidence is also emerging for roles of apolipoprotein E in the disease process that are independent of β-amyloid. Particular areas of interest are lipid metabolism, tau pathology, neuroenergetics, neurodevelopment, synaptic plasticity, the neurovasculature, and neuroinflammation. The intent of this article is to review the literature in each of these areas. © 2013 BioMed Central Ltd.

Cite

CITATION STYLE

APA

Wolf, A. B., Valla, J., Bu, G., Kim, J., Ladu, M. J., Reiman, E. M., & Caselli, R. J. (2013). Apolipoprotein E as a β-amyloid-independent factor in Alzheimer’s disease. Alzheimer’s Research and Therapy. https://doi.org/10.1186/alzrt204

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free